4.5 Review

Mitochondrial mechanisms of estrogen neuroprotection

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Volume 1800, Issue 10, Pages 1113-1120

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbagen.2009.11.013

Keywords

Estrogen; Estradiol; Non-feminizing estrogens; Mitochondria; Neuroprotection; Estrogen receptor; Alzheimer's disease

Funding

  1. NIH [P01 AG10485, P01 AG22550, P01 AG27956]
  2. NATIONAL INSTITUTE ON AGING [P01AG010485, P01AG027956, P01AG022550] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Mitochondria have become a primary focus in our search not only for the mechanism(s) of neuronal death but also for neuroprotective drugs and therapies that can delay or prevent Alzheimer's disease and other chronic neurodegenerative conditions. This is because mitochrondria play a central role in regulating viability and death of neurons, and mitochondrial dysfunction has been shown to contribute to neuronal death seen in neurodegenerative diseases. In this article, we review the evidence for the role of mitochondria in cell death and neurodegeneration and provide evidence that estrogens have multiple effects on mitochondria that enhance or preserve mitochondrial function during pathologic circumstances such as excitotoxicity, oxidative stress, and others. As such, estrogens and novel non-hormonal analogs have come to figure prominently in our efforts to protect neurons against both acute brain injury and chronic neurodegeneration. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available